Danilo De Gaspari

TL;DR: Male gender and higher impulsivity score, but not dose and kind of dopaminergic medications, were associated in PD with increased probability of impulsive disorders at MIDI, and individual susceptibility factors, such as high impulsivity and depression, underline abnormal behaviors in PD patients treated with stable dopaminaergic therapy.

TL;DR: It is found that PD patients with PG have abnormal resting state dysfunction of the mesocorticolimbic network possibly associated with a drug-induced overstimulation of relatively preserved reward-related neuronal systems, which supports the concept that PG is a "behavioral" addictive disorder.

TL;DR: An abnormal superior profile of the midbrain facilitates the distinction of PSP from PD and may support the clinical differential diagnosis of parkinsonism.

TL;DR: Clinical features in carriers were those of typical, idiopathic Parkinson's disease, however, behavioural abnormalities were frequent, suggesting a more widespread limbic involvement in G2019S carriers.

TL;DR: The improvement in specific PDQ‐39 subscores (mobility, activities of daily living, and stigma) suggests that depression affects patient self‐perception of motor function and further emphasizes the need for its treatment.